GT
COLL icon

Glenmede Trust’s Collegium Pharmaceutical COLL Stock Holding History

Glenmede Trust’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-1,945
Closed -$40K – 1432
2020
Q3 		$40K Sell
1,945
-337
-15% -$6.08K ﹤0.01% 1386
2020
Q2 		$39K Sell
2,282
-1,316
-37% -$25.8K ﹤0.01% 1372
2020
Q1 		$74K Hold
3,598
– – ﹤0.01% 1540
2019
Q4 		$74K Hold
3,598
– – ﹤0.01% 1540
2019
Q3 		$41 Buy
3,598
+368
+11% +$4.2K ﹤0.01% 1749
2019
Q2 		$42 Buy
3,230
+163
+5% +$2.18K ﹤0.01% 1765
2019
Q1 		$46 Hold
3,067
– – ﹤0.01% 1722
2018
Q4 		$52 Buy
+3,067
New +$52.5K ﹤0.01% 1565

Other funds holding COLL

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Glenmede Trust's COLL Position: Q4 2020 in Review

Glenmede Trust sold out of Collegium Pharmaceutical (COLL) in Q4 2020, closing a stake of 1,945 shares — an estimated $40K sold.

Glenmede Trust first reported a position in COLL in Q4 2018 and held it in 8 quarters. The position peaked at $74K in Q1 2020. 138 funds tracked by Wall St. Rank hold COLL as of Q4 2020.

  • Glenmede Trust reported no remaining Collegium Pharmaceutical position as of Q4 2020 after selling out during the quarter.
  • Glenmede Trust sold 1,945 Collegium Pharmaceutical shares in Q4 2020, an estimated $40K.
  • Glenmede Trust first reported a position in Collegium Pharmaceutical in Q4 2018 and held it in 8 quarters.
  • Glenmede Trust's Collegium Pharmaceutical position peaked at $74K in Q1 2020.
  • 138 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q4 2020.

Based on Glenmede Trust's 13F filing for Q4 2020, filed 16 Feb 2021.